Scopus BioPharma's Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (OTCQB: “SCPS”), a biotechnology company developing transformational therapeutics for serious diseases with significant unmet medical need, and its subsidiary, Duet BioTherapeutics Inc., which is developing novel immunotherapies to overcome treatment-resistant cancers, today announced that Marcin Kortylewski, Ph.D., Co-Founder and Senior Scientific Advisor of Duet and Professor of Immuno-Oncology at City of Hope, will be presentin

Related Keywords

California ,United States ,San Diego ,Scopus Biopharma ,Marcin Kortylewski ,Crescendo Communications ,Exchange Commission ,Company Form ,Scopus Biopharma Inc ,Duet Biotherapeutics Inc ,Senior Scientific Advisor ,Annual Meeting ,Tumor Associated Myeloid Cells ,Oligonucleotides Sensitizes Malignant Glioma ,Board Number ,Biopharma ,The Company ,Biotechnology Company ,Mmunotherapies ,City Of Hope ,Scopus ,Poster Board Number ,